Antipsychotic Medication Adherence Among Outpatients Attending the Centre Neuro Psycho Pathologique in Kinshasa: A Cross-Sectional Pilot Study of Treatment Attitudes, Insight, and Side-Effect Burden

Read full text Summarise with VIRAT
Authors: Yves Tshangala, Julienne Nzuzi Mananga, Jael Won Vuvu Ngimbi, Philippe Ntalaja Kabuayi
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and objective Incomplete adherence to antipsychotics commonly undermines relapse prevention and functional stabilization in severe mental disorders. Published data from the Democratic Republic of the Congo (DRC) are scarce. The objective of this pilot study was to estimate antipsychotic medication adherence among outpatients attending the Centre Neuro Psycho Pathologique (CNPP) in Kinshasa, DRC, and examine associations with treatment attitude, insight, and adverse effects using brief standardized instruments. Methods We conducted a cross-sectional pilot study from April to May 2025 at the outpatient service of the CNPP in Kinshasa, DRC. Adult patients (≥18 years) who had been prescribed at least one antipsychotic for a minimum duration of five weeks were included. Adherence was measured with the 10-item Medication Adherence Rating Scale (MARS). Adherence was dichotomized as good adherence (MARS ≥ 7) and poor adherence (MARS < 7). The Drug Attitude Inventory (DAI) was used to assess treatment attitude. Insight was assessed with the 8-item Birchwood Insight Scale (BIS-8). The Glasgow Antipsychotic Side-Effect Scale (GASS) measured the adverse effects of antipsychotics. Correlations between scales were examined by Spearman's rank correlation coefficient rho (ρ). Modelled associations were examined using logistic regression (exploratory, parsimonious models). Associations were explored using logistic regression. Significance was set at α = 0.05 with 95% confidence intervals (CI). Results A total of 62 outpatients were included: mean age 37.5 years, standard deviation (SD) 14.4; 37 (59.7%) were men. Poor adherence occurred in 28 patients (45.2%; 95% CI 33.4-57.5). Mean scores were 5.89 (SD 3.04) for MARS, 2.52 (SD 5.37) for DAI, 5.80 (SD 2.86) for BIS, and 20.63 (SD 20.84) for GASS. Of the enrolled patients, 39 (62.9%) had a positive treatment attitude, nine (14.5%) had good insight, and 12 (19.4%) had a severe side-effect burden. The MARS correlated with DAI (ρ=0.787; p

Fields of Study & Subjects

Medication Adherence and Compliance Schizophrenia research and treatment Mental Health Treatment and Access

Publication details

Journal / source
Cureus
Volume
18
Issue
3
Pages
e105916–e105916
Publication date
26 March 2026
Language
EN